BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Balaxi Pharmaceuticals has informed the exchange that its trading window for insiders will be closed starting October 1, 2025. The closure will remain in effect until 48 hours after the company declares its unaudited financial results for the quarter and half year ending September 30, 2025. The Board meeting date to consider these Q2/Half-Yearly results has not yet been announced and will be communicated later. This is a routine compliance measure under SEBI's Insider Trading Regulations to prevent designated persons from trading during the results announcement period.
This is a standard regulatory compliance disclosure with no material impact on shareholders or stock price. It signals that Q2 FY26 results will be announced soon, which investors should watch for.